Breaking the mold or business as usual? Meeting the challenges of HIV prevention in people With serious mental illness and substance use disorders

Clinical Psychology: Science and Practice

Volumn 14, Issue 1, 2007, Pages 34-38

  O'Cleirigh, Conall ^a   Safren, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cognitive behavioral therapy; Dual diagnosis; HIV AIDS; Prevention

Indexed keywords

ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE;

BEHAVIOR THERAPY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEALTH CARE ACCESS; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH CARE; NOTE; PATIENT COMPLIANCE; PREVENTIVE HEALTH SERVICE; PSYCHOSOCIAL CARE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; SYMPTOM; UNSPECIFIED SIDE EFFECT; VIRUS TRANSMISSION;

EID: 33847625406     PISSN: 09695893     EISSN: 14682850     Source Type: Journal    
DOI: 10.1111/j.1468-2850.2007.00060.x     Document Type: Note

References (24)

1. Carroll, K. M., & Onken L. S. (2005). Behavioral therapies for drug abuse. American Journal of Psychiatry, 162, 1452-1460.
2. Carroll, K. M., & Rounsaville, B. J. (2003). Bridging the gap: A hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatric Services, 54, 333-339.
3. Castillo, E., Palepu, A., Beardsell, A., Akagi, L., Yip, B., Montaner, J. S., et al. (2004). Outpatient pharmacy care and HIV viral load response among patients on HAART. AIDS Care, 16, 446-457.
4. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
5. Cohen, M. S. (1998). Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis. Lancet, 351 (Suppl. 3), 5-7.
6. Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. Journal of the American Medical Association, 285, 1460-1465.
7. Ironson, G., O'Cleirigh, C., Fletcher, M. A., Laurenceau, J. P., Balbin, E., Klimas, N., et al. (2005). Psychosocial factors predict CD4 and viral load change in men and women with HIV in the era of HAART. Psychosomatic Medicine, 67, 1013-1021.
8. Kitahata, M. M., Reed, S. D., Dillingham, P. W., Van Rompaey, S. E., Young, A. A., Harrington, R. D., et al. (2004). Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. International Journal of STD & AIDS, 15, 803-810.
9. Lazquez, M. V., Madueno, J. A., Jurado, R., Fernandez-Arcas, N., & Munoz, E. (1995). Human herpesvirus-6 and the course of human immunodeficiency virus infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 9, 389-394.
10. Leserman, J., Petitto, J. M., Gu, H., Gaynes, B. N., Barroso, J., Golden, R. N., et al. (2002). Progression to AIDS, a clinical AIDS condition and mortality: Psychosocial and physiological predictors. Psychosomatic Medicine, 32, 1059-1073.
11. Mayer, K. H., Safren, S. A., & Gordon, C. M. (2004). HIV care providers and prevention: Opportunities and challenges. Journal of Acquired Immune Deficiency Syndrome, 37, S130-S132.
12. Meade, C. S., & Weiss, R. D. (2007). Substance abuse as a risk factor for HIV sexual risk behavior among persons with severe mental illness: Review of evidence and exploration of mechanisms. Clinical Psychology: Science and Practice, 14, 23-33.
13. National Institute of Mental Health. (2005). Center for Mental Health Research on AIDS (9A-AS). Retrieved October 7, 2006, from http://www.nimh.nih.gov/dahbr/9a-as.cfm
14. Olatunji, B., Mimiaga, M., O'Cleirigh, C., & Safren, S. (2006). A review of treatment studies of depression in HIV. Topics in HIV Medicine, 14, 112-124.
15. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487-497.
16. Otto, M. W., O'Cleirigh, C., & Pollack, M. H. (in press). Attending to emotional cues for drug use: Bridging the gap between clinic and home behaviors. Science and Practice Perspectives.
17. Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S., & Rosenbaum, J. F. (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavior therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485-1490.
18. Pollack, M. H., Penava, S. A., Bolton, E., Worthington, J. J., Allen, G. L., Farach, F. J., et al. (2002). A novel cognitive-behavioral approach for treatment-resistant drug dependence. Journal of Substance Abuse Treatment, 23, 335-342.
19. Safren, S. A., Goldhammer, H., Knauz, R. O., Salomon, E., Capistrant, B., Driskell, J., et al. (2006). Feasibility and acceptability of an HIV prevention intervention for HIV-infected MSM incorporated into their primary care. Atlanta, GA: Proceedings of the National HIV Prevention Conference.
20. Safren, S., Hendriksen, E., Mayer, K., Pickard, R., & Otto, M. (2004). Cognitive behavioral therapy for HIV medication adherence and depression. Cognitive Behavior and Practice, 11, 415-424.
21. Safren, S. A., Knauz, R. O., O'Cleirigh, C., Lerner, J., Greer, J., Harwood, M., et al. (2006). CBT for adherence and depression in HIV. Paper presented at the Annual Meeting of the Association for the Advancement of Cognitive and Behavioral Therapies, Chicago, IL.
22. Soroudi, N., Perez, G. K., Pollack, M. H., Otto, M. W., Gonzalez, J. S., Greer, J. A., et al. (in press). CBT for adherence and depression (CBT-AD) in HIV-infected methadone patients. Cognitive and Behavioral Practice.
23. Substance Abuse and Mental Health Services Administration. (2006). SAMHSA Action Plan HIV/AIDS & Hepatitis, FY 2006 and FY 2007. Retrieved October 7, 2006, from http://www.samhsa.gov/Matrix/SAPHIV.aspx
24. Volkow, N. D. (2006). Challenges in HIV/AIDS research. NIDA Notes, 20 (6). Retrieved October 7, 2006, from http://www.nida.nih.gov/NIDA_notes/NNvol20N6/DirRepVol20N6.html